SEC Form 4 · accession 0001209191-18-030617
FATE THERAPEUTICS INC · FATE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stewart Abbot
Officer — Chief Development Officer
Period of report
May 15, 2018
Accepted (ET)
May 16, 2018 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2018 | M | 2,916 | $4.89 | A | 46,779 | D | |
| Common Stock | May 15, 2018 | M | 18,138 | $6.90 | A | 64,917 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $4.89 | May 15, 2018 | M | 2,916 | D | — | Oct 15, 2025 | Common Stock | 2,916 | 67,084 | D |
| Stock Option (right to buy)F2,F3 | $6.90 | May 15, 2018 | M | 18,138 | D | — | Aug 3, 2025 | Common Stock | 18,138 | 51,862 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on November 12, 2015, such that this option is fully exercisable on October 12, 2019, subject to the recipient's continued service relationship with the Issuer. This option is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.
- F2Not applicable.
- F3The shares subject to the option shall vest and become exercisable at the rate of 1/4th of the shares on July 13, 2016 and 1/48th of the shares each month thereafter such that this option is fully exercisable on July 13, 2019. This option is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer.